FDA clears Ferring’s drug substance manufacturing scale-up process for Adstiladrin
The approval will enable the Swiss company to scale up its drug substance manufacturing process for ADSTILADRIN at…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
13 Jun 23
The approval will enable the Swiss company to scale up its drug substance manufacturing process for ADSTILADRIN at…
13 Jun 23
Under the partnership, Curigin will use Charles River's expertise in contract development and manufacturing organisation solutions for supporting…
13 Jun 23
Signals Research Suite integrates workflows across biology, chemistry and materials new product development to arm scientists with better…
13 Jun 23
Product eliminates the need for two discrete syringe preparations and administrations, which helps increase efficiency for hospitals and…
12 Jun 23
The deal will give Novartis two late-stage medicines for the treatment of IgA nephropathy in the form of…
12 Jun 23
The ALPHA trial is designed to evaluate the efficacy and safety of danicopan as an add-on to C5…
12 Jun 23
The panel’s backing was based on the sBLA, which includes findings from Eisai’s global confirmatory Phase 3 Clarity…
12 Jun 23
The partnership intends to use in vivo electrophysiology solutions to drive neuroscience research and accelerate neurological drug discovery…
12 Jun 23
Survey of Unmet Needs in chronic myeloid leukemia (CML SUN) data signal need for amplified patient voice during…
12 Jun 23
The new platform is designed to enable the end-to-end analysis and clinical reporting of nanopore sequencing, empowering clinical…